We conducted an international, open-label, randomized, blinded-outcome-assessment trial involving 1284 patients who had undergone successful catheter ablation for atrial fibrillation at least 1 year ...

More people have atrial fibrillation (AFib) than any other kind of irregular heartbeat. And the numbers are only expected to go up as people live longer with heart conditions that go along with it.

Johnson & Johnson has initiated the PERSIGMA randomized controlled trial (RCT), one of the first randomized studies evaluating competitive pulsed field ablation (PFA) technologies. In this rapidly ...

In the U.S., atrial fibrillation (AF), a heart condition that causes an irregular heartbeat in the upper chambers of the heart, affects up to one in three people in their lifetime. Significant ...

Pulse Biosciences PLSE recently reached a key milestone with the FDA’s approval of its Investigational Device Exemption (IDE) to initiate the NANOCLAMP AF study, evaluating its Nanosecond Pulsed Field ...